Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
Ran ZhaoBu Young ChoiLixiao WeiMangaladoss FredimosesFanxiang YinXiaorong FuHanyong ChenKangdong LiuJoydeb Kumar KunduZigang DongMee-Hyun LeePublished in: British journal of pharmacology (2020)
Acetylshikonin suppressed growth of colorectal cancer cells by attenuating TOPK signalling. Targeted inhibition of TOPK by acetylshikonin might be a promising new approach to the treatment of colorectal cancer.